Accelerated Development and Manufacturing of Oral Small Molecules to Be Discussed by Catalent Applied Drug Delivery Institute and JLABS
March 31, 2023
March 31, 2023
SOMERSET, New Jersey, March 31 -- Catalent Inc., a pharma, biotech and consumer health company, issued the following news on March 30, 2023:
The Catalent Applied Drug Delivery Institute, which was established as a cross-industry consortium to accelerate the adoption of advanced drug delivery technologies, today announced that it will hold a symposium in affiliation with Johnson & Johnson Innovation - JLABS (JLABS), entitled "The Road to IND: Accelerating Development & M . . .
The Catalent Applied Drug Delivery Institute, which was established as a cross-industry consortium to accelerate the adoption of advanced drug delivery technologies, today announced that it will hold a symposium in affiliation with Johnson & Johnson Innovation - JLABS (JLABS), entitled "The Road to IND: Accelerating Development & M . . .